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ABSTRACT
Objective To compare the effectiveness of elective single
embryo transfer versus double embryo transfer on the
outcomes of live birth, multiple live birth, miscarriage,
preterm birth, term singleton birth, and low birth weight
after fresh embryo transfer, and on the outcomes of
cumulativelivebirthandmultiplelivebirthafterfreshand
frozen embryo transfers.
Design One stage meta-analysis of individual patient
data.
Data sources A systematic review of English and non-
English articles from Medline, Embase, and the Cochrane
Central Register of Controlled Trials (up to 2008).
Additional studies were identified by contact with clinical
experts and searches of bibliographies of all relevant
primary articles. Search terms included embryo transfer,
randomised controlled trial, controlled clinical trial,
single embryo transfer, and double embryo transfer.
Review methods Comparisons of the clinical
effectivenessofcleavagestage(day2or3)electivesingle
versusdoubleembryotransferafterfreshorfrozeninvitro
fertilisation (IVF) or intracytoplasmic sperm injection
(ICSI) treatments were included. Trials were included if
the intervention differed only in terms of the intended
number of embryos to be transferred. Trials that involved
only blastocyst (day five) transfers were excluded.
Results Individual patient data were received for every
patient recruited to all eight eligible trials (n=1367). A
totalof683and684womenrandomisedtothesingleand
doubleembryotransferarms,respectively,wereincluded
in the analysis.Baseline characteristics in the two groups
were comparable. The overall live birth rate in a fresh IVF
cycle was lower after single (181/683, 27%) than double
embryo transfer (285/683, 42%) (adjusted odds ratio
0.50, 95% confidence interval 0.39 to 0.63), as was the
multiple birth rate (3/181 (2%) v 84/285 (29%)) (0.04,
0.01to0.12).Anadditionalfrozensingleembryotransfer,
however, resulted in a cumulative live birth rate not
significantly lower than the rate after one fresh double
embryo transfer (132/350 (38%) v 149/353 (42%) (0.85,
0.62 to 1.15), with a minimal cumulative risk of multiple
birth (1/132 (1%) v 47/149 (32%)). The odds of a term
singleton birth (that is, over 37 weeks) after elective
single embryo transfer was almost five times higher than
the odds after double embryo transfer (4.93, 2.98 to
8.18).
Conclusions Elective single embryo transfer results in a
higher chance of delivering a term singleton live birth
compared with double embryo transfer. Although this
strategy yields a lower pregnancy rate than a double
embryo transfer in a fresh IVF cycle, this difference is
almost completely overcome by an additional frozen
single embryo transfer cycle. The multiple pregnancy rate
after elective single embryo transfer is comparable with
that observed in spontaneous pregnancies.
INTRODUCTION
Increasing success after in vitro fertilisation (IVF) and
intracytoplasmic sperm injection has been accompa-
nied by concerns about rising rates of multiple
pregnancies.
1 Multiple pregnancy is associated with
increased maternal and perinatal morbidity and mor-
tality, as well as increased costs to the health service.
1-3
These concerns have prompted a change in practice
that has led to a reduction in triple embryo transfers
and an increase in double embryo transfers. In 2006,
however, twins accounted for nearly 20% of all live
births in Europe resulting from IVF.
4
Considerationsofsafetyinthecontextofexpanding
use of assisted reproduction has encouraged many
clinics in northern Europe to adopt a policy of elective
single embryo transfer as an effective means of mini-
mising the rate of twin pregnancy associated with
IVF.
25 The Human Embryology and Fertilisation
Authority (HFEA), which regulates IVF in the United
Kingdom, now advocates the use of elective single
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births associated with IVF
6 and recommends a
national target twin rate of under 10%.
7 A systematic
review of randomised trials with aggregated data on
elective single versus double embryo transfer con-
cluded that, though single transfer reduced the odds
of multiple pregnancies, it halved the odds of live
birth per fresh cycle.
8 Subsequent transfer of a single
frozen thawed embryo resulted in comparable cumu-
lativelivebirthoutcomestothoseafterdoubleembryo
transfer. Since that review was performed, however,
results from other relevant unpublished trials have
become available (M Davies, University of Adelaide,
personal communication).
910 Also, meta-analysis of
publishedaggregateddatacannotprovideinformation
on which subgroups of women might be most likely to
benefitfrom elective single embryotransfer or present
data on important outcomes such as the birth of a
healthy singleton baby at term, which have not been
reported in existing trials. This is important,as charac-
teristicsofthepatientsandembryosarekeyprognostic
indicesthatcaninfluencechancesofalivebirth,aswell
as multiple pregnancies.
11
Meta-analysis of individual patient data has several
advantages over a traditional review of published
data,
12 including the ability to carry out data checks,
standardiseoutcomemeasures,andperformappropri-
ate subgroup analyses.
13 We carried out a systematic
review of randomised controlled trials to compare the
effectiveness of cleavage stage (day 2 or 3) elective sin-
gle versus double embryo transfer on the outcomes of
live birth and multiple live birth after a fresh embryo
transfer and on the outcomes of cumulative live birth
and multiple live birth after fresh and frozen embryo
transfers.Ouruseofindividualpatientdataallowedus
to address some of the acknowledged shortcomings of
existing meta-analyses of aggregated data, including
assessment of study quality, intention to treat analysis
of all randomised women, and subgroup analysis
based on important prognosticators such as age, dura-
tion of infertility, and embryo quality. In addition, we
used the combined dataset of randomised women to
investigate key outcomes such as term singleton live
birth, miscarriage, and preterm birth not previously
reported by the relevant trials.
METHODS
The systematic review was based on a protocol
designed with widely recommended methods to
allow us to comply with reporting guidelines.
13-16 We
undertook a “one stage” meta-analysis of individual
patient data from randomised trials of cleavage stage
(day2or3)singleversusdoubleembryotransfer.
131718
Literature search and study selection
We searched Medline and Embase databases up to
2008 using relevant terms and word variants for the
interventions and study design. The detailed search
strategy is in appendix 1 on bmj.com. We also hand
searchedbibliographiesofallrelevantprimaryarticles
and reviews to identify any articles missed by the
electronic searches. Several trial registers were
searched to identify ongoing trials and experts were
contacted to identify further studies. No language
restriction was applied.
Studies were selected in a two step process. We first
scrutinised the citations identified by the electronic
searches and then obtained full manuscripts of all the
citations that met or were thought likely to meet the
predetermined inclusion criteria based on criteria for
patientsatentry,typeofintervention,andstudydesign.
Types of studies
Only randomised controlled trials that compared the
clinical effectiveness of cleavage stage elective single
with double embryo transfer were deemed eligible
for inclusion. Quasi-randomised trials were excluded,
as were trials with other co-interventions. Ongoing
trials and crossover trials were considered for inclu-
sion—the latter only if data from before the crossover
occurred were available.
Types of participants
Women undergoing IVF or intracytoplasmic sperm
injection, or both, with their own oocytes were consid-
ered eligible for inclusion.
Type of intervention
We included comparisons of the clinical effectiveness
of elective singleversusdouble cleavage stage embryo
transfer after fresh or frozen IVF or intracytoplasmic
sperm injection treatments. Frozen treatment cycles
were included if the intention was to follow the rando-
mised allocation of electively transferring one or two
embryos.Trialsthatinvolvedonlyblastocyst(dayfive)
transferswereexcludedbecauseoftheirhighersuccess
rates,
19 which could lead to biased results.
Trialswereincludediftheinterventiondifferedonly
in terms of the intended number of embryos to be
transferred—that is, similar protocols were used for
controlled ovarian stimulation, embryo culture, and
the replacement of embryos.
Types of outcome measures
The primary outcomes were live births and multiple
livebirthsaftertheinitialfreshembryotransfer,cumu-
lative live births, and cumulative multiple live births
(after fresh and frozen embryo transfers accruing
from a single oocyte retrieval).
Secondary outcomes included miscarriage rate and
perinataleventssuchasratesofpretermdelivery,term
singleton delivery, and delivery of at least one low
birthweightbaby(<2500g).Thedenominatorformis-
carriage rate was defined by using all pregnancies,
including biochemical pregnancy.
Data collection
We sought individual patient data from all identified
eligible trials. Every attempt was made to contact the
corresponding authors of published and registered
RESEARCH
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Authors were supplied with a data extraction sheet
andaskedtosupplyanonymiseddataforeverypatient
in the trial in a password protected or encrypted data-
base. Received data were merged into a specifically
constructed master database. The data were subjected
to standard range and internal consistency checks. In
addition, the results from the review’s analysis were
cross checked against the published reports of the
trials. Authors were contacted for clarification where
discrepancies existed and asked to supply missing
data when possible.
Data items
From each trial we extracted information on the char-
acteristics of the couples (body mass index (BMI),
woman’s age, duration, type and cause of infertility,
and type of treatment); the characteristics of the cycles
(randomised treatment (elective single embryo trans-
fer or double embryo transfer), number of embryos
available for transfer, day of transfer, and number of
blastomeres); the type of outcome (live birth, multiple
live birth, cumulative live birth, cumulative multiple
live birth, miscarriage, preterm delivery, term single-
ton birth, and low birth weight).
Risk of bias in individual studies
To ascertain validity, we assessed all selected trials for
their methodological quality on the basis of informa-
tionreportedintheoriginalpublishedpapers,trialpro-
tocols (for non-published trials), and responses to
specific queries to the authors. Study quality was scru-
tinised by checking the adequacy of randomisation,
comparability of groups at baseline (examining base-
line characteristics for any substantive differences),
theuseofblinding(whereappropriate),theuseofinten-
tion to treat analysis, the completeness of follow-up,
reliabilitywithapriorisamplesizeestimation,andgen-
eralisability with a description of the sample recruited.
The adequacy of randomisation was assessed by
exploringmethodsusedforsequencegeneration,treat-
ment allocation, and allocation concealment. When
these details were unclear in the initial publication, we
contacted authors to provide further clarification.
Statistical analysis
Receipt of data from each trial was followed by checks
to ensure the accuracy of the data, integrity of rando-
misation, and the extent of follow-up. Standard range
and internal consistency checks were used to assess
accuracy.Finalanalyseswerebasedonallpatientsran-
domised with the intention to treat principle, and the
data were checked to confirm that no patients were
excluded after trial entry and that key prognostic vari-
ables were similar in the randomised groups. Queries
were resolved in discussion with the relevant trialists,
who received results based on re-analysis of their ori-
ginal trial data.
Trial heterogeneity
We carried out formal checks for statistical heteroge-
neity between the trials by summarising randomised
treatment effects for each trial using odds ratios
obtainedfromtheindividualpatientdata.TheI
2statis-
tic was applied to these summary data to describe the
percentage of variation across trials caused by hetero-
geneity, as opposed to sampling error. A value greater
than 50% was considered to show substantial
heterogeneity.
20 To assess the risk of bias across trials,
we used funnel plots and formally assessed their sym-
metry using the Horbold-Egger test.
Meta-analysis of individual patient data
On the condition that no trial heterogeneity was pre-
sent,wecarriedouta“onestage”meta-analysisofindi-
vidual patient data. A logistic regression model was
fitteddescribingtheeffectofelectivesingleversusdou-
ble embryo transfer on live birth, adjusted for trial.
Trial was included as a fixed effect dummy variable
that allowed the log odds to vary across the trials.
This model was further adjusted separately for dura-
tion (years) and primary cause of infertility (male fac-
tor, female factor, unexplained, mixed/other), type of
infertility (primary or secondary), type of treatment
(IVF or intracytoplasmic sperm injection), woman’s
age and BMI, number of embryos available for trans-
fer,dayoftransfer,andqualityofembryostransferred.
Embryo quality was defined by the number of blasto-
meres observed, which was the only consistent objec-
tive measure used across all the included trials. Grade
Awasusedtodescribeallembryosthatcontainedfour
cellsondaytwoafterfertilisationormorethansixcells
onday threeafterfertilisation. Allother embryoswere
graded as grade B. When two embryos were trans-
ferred, the higher grade was included in the model.
This classification was informed by data on the
Records after duplicates removed (n=1383)
Records screened (n=1383)
Full text articles assessed for eligibility (n=11)
Studies included in qualitative synthesis (n=8)
Additional records identified
through other sources (n=3)
Records identified through
database searching (n=1539)
Studies included in quantitative synthesis (meta-analysis) (n=8)
Records excluded (n=1372)
Full text articles excluded (n=3):
 Blastocyst transfers only (n=1)
 Different ovarian stimulation
    protocols used in two arms (n=1)
 Quasi-randomised trial (n=1)
Fig 1 | Flow diagram of study selection
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successful implantation rate.
2122
We includedany ofthe abovecovariateswithP<0.3
in a backward stepwise logistic regression modelling
procedure to determine multiple covariates that,
together, had a significant effect on the outcome,
while holding the trial and elective single versus dou-
bleembryotransfereffectsfixed.Asimilarprocesswas
performed for the other primary and secondary out-
comes.Theoddsratiosandtheir95%confidenceinter-
vals of all outcomes were calculated from the models
based on the intention to treat principle. In the pre-
sence of substantial heterogeneity between trials or
over-fitting because of small numbers in each trial, we
performed sensitivity analyses by excluding the
offending trial(s).
Table 1 |Description of identified trials examining effectiveness of single embryo transfer (SET) versus double embryo transfer (DET)
Authors Details Interventions Clinical outcomes
Included published trials
Gerris et al, 1999
29 First IVF/ICSI cycle. Female age <34. At least one top
quality embryo should be available
SET fresh v DET fresh Clinicalongoingpregnancy(at least one gestationalsac
with heartbeat), multiple pregnancy, biochemical
pregnancy (positive test), implantation, clinical
miscarriage (loss of at least one amniotic sac identified
at sonography), clinical ectopic pregnancy (required
surgical intervention)
Lukassen et al, 2005
27 First IVF/ICSI cycle. Female age <35. FSH <10I U/L. At
least one good quality embryo should be available
SET fresh + SET fresh v DET fresh Cumulative live birth, singleton live birth, multiple live
birth, clinical ongoing pregnancy (at least one
gestational sac with heartbeat), abortion, ectopic
pregnancy, preterm birth (<37 weeks’ gestation), low
birth weight (<2500 g), perinatal death rates and live
birth rate after only one treatment cycle
Martikainen et al, 2001
30 Fresh IVF/ICSI treatment in four centres. No more than
one previous failed treatment. Age was not taken into
account and first two cycles eligible in two centres. In
other two centres, age <36 in first cycle only. At least
four good quality embryos should be available
SET fresh v DET fresh Live birth, singleton live birth, twin live birth, clinical
pregnancy (confirmed by ultrasonography),
implantation, miscarriage, ectopic pregnancy, preterm
birth (<37 weeks’ gestation), low birth weight (<2500 g)
rates
Thurin et al, 2004
26 First or second IVF cycle. At least two good quality
embryos available for transfer or freezing. Female age
<36
SET fresh + SET frozen v DET fresh Cumulative live birth, biochemical pregnancy (positive
test),implantation(numberofgestationalsacs/number
of embryos transferred), multiple live birth,
spontaneous abortion, ectopic pregnancy
Van Montfoort et al, 2006
28 First IVF cycle. Participants had to have normal
fertilisation of at least two oocytes (two pro-nuclear
stage embryos) irrespective of woman’s age or embryo
quality
SET fresh v DET fresh Biochemical pregnancy (positive test), clinical
pregnancy(atleastonegestationalsacwithheartbeatat
12 weeks’ gestation), twin pregnancy, abortion
Included unpublished data
Thurin. Elective single embryo
transfer [dissertation]. Gothenburg
University, 2005
9
Femaleage ≥36years.FirstorsecondIVF/ICSIcycle.At
least two good quality embryos available
SET fresh + SET frozen v DET fresh Cumulative live birth, biochemical pregnancy (positive
test),implantation(numberofgestationalsacs/number
of embryos transferred), multiple live birth,
spontaneous abortion, ectopic pregnancy
Davies M. Australian study of single
embryo transfer (ASSET)
Female age <35 if no previous ART pregnancy, <40 if
previous ART pregnancy. At least four good quality
embryos or at least three if previous ART pregnancy
successful
SET fresh versus DET fresh Cumulative live birth, twin live birth, clinical ongoing
pregnancy (fetal heartbeat), complications during
pregnancy, delivery and neonatal period, perinatal
mortality and morbidity, use of neonatal intensive care
Bhattacharya S. Efficacy and cost
effectiveness of selective single
embryo transfer (ECOSSE)
10
Female age ≤37. First or second IVF/ICSI cycle. At least
four good quality embryos at time of embryo transfer
SETfresh+multipleSETfrozenvDET
fresh + multiple DET frozen
Cumulative live birth, twin live birth, clinical pregnancy
(at least one gestational sac with heartbeat),
biochemical pregnancy (positive test), miscarriage,
ectopic pregnancy preterm delivery, low birth weight,
congenital abnormality
Excluded trials
Gardner et al, 2004
24 Involved only blastocyst (day 5) transfers SET fresh v DET fresh Clinicalongoingpregnancy(at least one gestationalsac
with heartbeat), twin pregnancy, implantation (number
of gestational sacs with heartbeat/number of embryos
transferred)
Heijnen et al, 2007
23 Different ovarian stimulation protocols used in two
arms
Mild ovarian stimulation (GnRH)
antagonistco-treatment)+SETfresh
+ SET/DET frozen as per patient’s
preference v standard ovarian
stimulation (GnRH agonist long
protocol) + DET fresh + SET/DET
frozen as per patient’s preference.
More than one fresh cycle
Cumulative term (≥37 weeks’ gestation) live birth, term
singleton live birth, late preterm (32-37 weeks’
gestation) live birth, early preterm (< 32 weeks’
gestation) live birth, clinical pregnancy (positive
heartbeat)rateswithin1yearofrandomisation.Multiple
pregnancy. Time to pregnancy leading live birth
Moustafa et al, 2008
25 Quasi-randomised trial with alternate days used as
method of randomisation
SETfresh+multipleSETfrozenvDET
fresh + multiple DET frozen
Live birth, clinical pregnancy (positive heartbeat),
multiple pregnancy. Gestational age at miscarriage,
gestational age at birth, birth weight
IVF=in vitro fertilisation; ISCI=intracytoplasmic sperm injection; FSH=follicle stimulating hormone; SET=single embryo transfer; DET=double embryo transfer; GnRH=gonadotrophin releasing
hormone; ART=assisted reproductive technology.
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We fitted further logistic regression models to investi-
gate the effect of single versus double embryo transfer
onlivebirthsandmultiplelivebirthsbetweendifferent
subgroups of women. The subgroups were woman’s
age (<33 and ≥33), duration of infertility (<3 and
≥3 years), and embryo quality (grade A and B). Sub-
groups were coded as binary factors and included in
the model along with trial and single versus double
embryo transfer. To investigate whether the effect of
single versus double embryo transfer on live birth dif-
fered among the subgroups, we added an interaction
term to the model of single versus double embryo
transfer by subgroup factor.
In addition, for singleton live births only, we com-
pared birth weight between single versus double
embryo transfer using a linear regression model
adjusted for trial. Because of the small percentage of
missing data, all analyses were undertaken with com-
plete data only. We used Review Manager (RevMan)
v5.0 (Nordic Cochrane Centre, Cochrane Collabora-
tion, Copenhagen) and SAS v9.1 (SAS Institute, Cary,
USA) for statistical analyses.
RESULTS
Study selection
Electronic searches identified 1539 citations, from
which we assessed 11 full text articles for eligibility.
Three of these trials were excluded for different
reasons
23-25 (table 1). Eight trials were considered to
be suitable for inclusion in the review (fig 1). Three
were unpublished trials.
910 One was a pilot trial,
which was published only as part of a PhD
dissertation.
9 The other two were externally funded
national trials, in Australia (National Health and Med-
ical Research Council Grant no: 158006) (M Davies,
University of Adelaide, personal communication) and
the UK.
10 The Australian trial, known as the “Austra-
lian study of single embryo transfer (ASSET),” was
stopped because its implementation immediately and
substantially altered patients’ decision making, which
more than tripled the rates of elective single embryo
transferduringthestudyperiodandreducedparticipa-
tion rates (M Davies, University of Adelaide, personal
communication). The UK trial, known as the “efficacy
and cost effectiveness of selective single embryo trans-
fer (ECOSSE) study” was stopped because of poor
recruitment.
Study characteristics
Table 1 describes the characteristics of the eight trials.
Allcomparedonefreshcycleofelectivesingleembryo
transfer with one fresh double embryo transfer. Addi-
tionally, two trials also compared fresh elective single
embryotransferfollowedbyonefrozensingleembryo
transfer cycle with one fresh double embryo
transfer,
926whileonetrialcomparedtwofreshelective
single embryo transfer cycles versus one fresh double
embryo transfer.
27
As entry criteria were slightly different amongtrials,
we could not exclude an element of clinical heteroge-
neity. With the exception of two trials,
928all the trials
included women with “good prognoses”—that is,
younger women in their first or second IVF treatment
cycleswithgoodembryoquality.Theagecriteriawere
different in the eight included studies. The upper age
limit was 34, 35, and 36, respectively, in Gerris et al,
29
Lukassen et al,
27 and Thurin et al.
26 In a multicentre
Finnish trial, one of the centres did not take the age of
thewomanintoaccount,buttheothercentresincluded
only women aged under 36 in their first treatment
cycle.
30 There was no upper age limit for entry into
van Montfoort et al
28 or Thurin,
9 while the upper age
limits for Davies and Bhattacharya were 35 and 37,
respectively.
10 All trials included women with good
quality embryos, apart from one that included
women with at least two normally fertilised oocytes.
28
Criteria for embryo quality differed in the individual
trials but generally involved visual morphological
assessment, in addition to the number of blastomeres.
Ovarian stimulation protocols and oocyte retrieval,
embryo culture, and embryo transfer techniques var-
ied slightly among the different trials. Though nearly
all trials involved only cleavage stage transfers, one
published and one unpublished study included a few
blastocyst (day five) transfers,
926 which we excluded
from the analysis because of small numbers.
Individual patient data were received for every
patient recruited to all eight eligible trials (n=1367).
Live birth
  Bhattacharya10
  Davies
  Gerris29
  Lukassen27
  Martikainen30
  Thurin 2004
26
  Thurin 2005
9
  Van Montfoort
28
Total
Test for heterogeneity: χ2=4.09, df=7, P=0.77, I2=0%
Test for overall effect: z=5.92, P<0.001
Multiple live birth
  Bhattacharya10
  Davies
  Gerris29
  Lukassen
27
  Martikainen30
  Thurin 200426
  Thurin 2005
9
  Van Montfoort
28
Total
Test for heterogeneity: χ2=5.39, df=7, P=0.61, I2=0%
Test for overall effect: z=5.82, P<0.001
1.20 (0.23 to 6.19)
0.54 (0.10 to 2.93)
0.22 (0.07 to 0.71)
0.64 (0.28 to 1.47)
0.61 (0.30 to 1.21)
0.51 (0.37 to 0.70)
0.54 (0.13 to 2.21)
0.42 (0.25 to 0.70)
0.50 (0.40 to 0.63)
0.28 (0.01 to 8.42)
0.43 (0.01 to 14.08)
0.27 (0.03 to 2.68)
0.07 (0.00 to 1.40)
0.07 (0.01 to 0.63)
0.02 (0.00 to 0.17)
0.48 (0.02 to 14.70)
0.06 (0.00 to 1.02)
0.07 (0.03 to 0.17)
1.3
1.8
5.9
6.8
9.9
49.4
2.6
22.5
100.0
2.1
1.6
5.2
8.2
14.0
54.0
1.6
13.3
100.0
0.05 0.2 1 5 20
Study
Favours
DET
Favours
eSET
0.01 0.1 1 10 100
Favours
eSET
Favours
DET
Fixed odds ratio
(95%)
Fixed odds ratio
(95%)
Weight
(%)
6/11
3/13
9/26
14/54
22/75
91/330
4/20
32/154
181/683
0/6
0/3
1/9
0/14
1/22
1/91
0/4
0/32
3/181
Elective single
embryo transfer
6/12
5/14
19/27
19/54
28/69
142/331
7/22
59/154
285/683
1/6
1/5
6/19
6/19
11/28
46/142
1/7
12/59
84/285
Double embryo
transfer
Fig 2 | Odds ratios of elective single embryo transfer v double embryo transfer for separate
trials and pooled odds ratios for live births and multiple live births
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(see appendix 2 on bmj.com). With the exception of
BMI, which was missing for nearly 17%, all required
variables were over 95% complete.
Risk of bias within studies
The methodological quality of the included studies
varied (table 2). Three of the published trials
262730
and all three unpublished trials (M Davies, University
of Adelaide, personal communication)
910 explicitly
mentioned computer generated randomisation. One
trialusedanon-transparentboxcontainingsealedopa-
que envelopes,
28 and one trial did not mention details
of the method of randomisation used.
29 The first
author of the latter trial, however, later confirmed
that randomisation was performed at the time of
embryo transfer by laboratory staff using a computer
generated randomisation list (J Gerris, personal
communication).
Concealment of allocation was adequate and expli-
citly described in Thurin et al,
26 Lukassen et al,
27 and
van Montfoort et al
28 but not in Martikainen et al.
30
Gerrisetalstatedonlythattheyusedexternalconceal-
mentandgave nofurtherdetails.
29 Allthe more recent
unpublishedtrialsusedacceptablemethodsofconceal-
ment of allocation.
910
Four studies performed intention to treat
analysis.
926-28 Although not explicitly mentioned in
the original publication, the first authors of two
trials
2930 later confirmed that they had performed
intention to treat analysis.
Only one of the published studies was double
blinded—that is, neither the patient nor the physician
knew whether one embryo or two embryos had been
transferred.
26 Two unpublished trials used double
blinding at the time of embryo transfer.
910 Davies et
al enforced double blinding at the time of embryo
transfer, but the participants were unblinded when
they received photographs of the transferred embryo
(s) (M Davies, University of Adelaide, personal com-
munication). In one study only the patients were
blinded,buttheyweretoldimmediatelyafterthetrans-
fer whether they received single or double embryo
transfer.
28 Other trials were not blinded. Thurin et
al,
26 Lukassen et al,
27 and van Montfoort et al
28
reported an a priori power calculation; Gerris et al
29
and Martikainen et al
30 did not.
Results of individual studies
Appendix 3 on bmj.com shows characteristics of the
women by trial. Before conducting the analysis of indi-
vidual patient data, we carried out an aggregated meta-
analysisoftheindividualtrialstocheckforheterogeneity
(fig 2). The pooled odds ratio for elective single embryo
transfer versus double embryo transfer was 0.50 (95%
Table 2 |Quality assessment of studies on single embryo transfer versus double embryo transfer included in meta-analysis
Target population
described adequately
Sample size
calculation
Adequate
randomisation Blinding
Intention to treat
analysis performed
Two arms comparable
at baseline
Follow-
up >80%
Published trials (details retrieved from published paper and response from authors)
Gerris et al, 1999
29 Yes No Not stated in paper.
Laterconfirmedasyes
by author
Not stated in paper.
Later confirmed as
yes by author
Not stated in paper. Later
confirmed as yes by author
Yes Yes
Lukassen et al, 2005
27 Yes Yes Yes No Yes Yes Yes
Martikainen et al, 2001
30 Yes No Yes Not stated in paper.
Later confirmed as
yes by author
Not stated in paper. Later
confirmed as yes by author
Yes Yes
Thurin et al, 2004
26 Yes Yes Yes Yes Yes Yes Yes
Van Montfoort et al, 2006
28 Yes Yes Yes Yes Yes Yes Yes
Unpublished trials (details retrieved from trial protocols and response from authors)
Thurin A, 2005
9 Yes Yes Yes Yes Yes Yes Yes
Davies M, 2003 Yes Yes Yes No Results not previouslyanalysed Yes Yes
Bhattacharya S, 2006
10 Yes Yes Yes Yes Results not previouslyanalysed Yes Yes
Table 3 |Characteristics of couples at randomisation by
randomised group: elective single embryo transfer (eSET) or
double embryo transfer (DET). Figures are numbers
(percentages) unless stated otherwise
eSET
(n=683)
DET
(n=684)
Mean (SD) age of woman (years) 31.3 (3.5) 31.4 (3.4)
Missing 3 (0.4) 2 (0.3)
Median (IQR) BMI of woman 23.3
(21.3-26.1)
23.3
(21.1-26.3)
Missing 115 (17) 110 (16)
Type of infertility:
Primary 507 (74) 489 (72)
Secondary 161 (24) 182 (27)
Missing 15 (2) 13 (2)
Median (IQR) duration of infertility (years) 3.0(2.1-4.4) 3.0 (2.0-4.0)
Missing 11 (1.6) 10 (1.5)
Primary cause of infertility:
Male 280 (41) 276 (40)
Female 170 (25) 177 (26)
Unexplained 109 (16) 141 (21)
Other/mixed 122 (18) 88 (13)
Missing 2 (0.3) 2 (0.3)
SD=standard deviation; IQR=interquartile range.
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(0.03 to 0.17) for multiple live births. The I
2 statistic was
0% for both outcomes, suggesting no significant hetero-
geneitybetweentrialsandthereforejustifiedtheanalysis
ofindividualpatientdata.TheHorbold-Eggertestresult
wasnotsignificantforbothoutcomes,suggestingnosig-
nificant publication bias.
Synthesis of results
The two randomised groups of women were compar-
ableintermsofbaselinecharacteristics(table 3).Inthe
women, the mean age was 31.3 (SD 3.5) in the single
embryo transfer group and 31.4 (SD 3.4) in the double
embryo transfer group, and the median BMI was 23.3
(interquartile range 21.3-26.1) and 23.3 (21.1-26.3),
respectively. The most common cause of infertility
wasmalefactorinfertility(41%and40%,respectively).
Table 4 summarises details of treatment in the fresh
cycle. In both groups the median number of embryos
available was five, and most embryo transfers were
performed on day two (79% in both groups). The allo-
cated treatment was received by 677/683 (99%)
patients in the elective single embryo transfer arm
and 676/684 (99%) patients in the double embryo
transfer arm. Only one (0.1%) woman was lost to fol-
low-up (in the double embryo transfer group). Thus
683 women in the elective single embryo transfer
arm and 683 in the double embryo transfer arm were
included in the analysis of primary outcomes.
Meta-analysis of clinical outcomes with individual patient
data
Live birth
After one fresh cycle, the live birth rate in the elective
single embryo transfer group (181/683, 27%) was
lower than in the double embryo transfer group (285/
683, 42%). The odds of a live birth in women rando-
mised to single embryo transfer were half that for
women who received a double embryo transfer
(table 5). When we did a backward stepwise selection
process, the adjusted odds ratio remained similar
(adjusted odds ratio 0.50, 95% confidence interval
0.39 to 0.63). A few women 72/1366 (5%) were
excluded from this adjusted analysis because of miss-
ing values for the covariates. The covariates that were
included in this adjusted model were the grade of the
embryos transferred, type of treatment, and the pri-
mary cause of infertility. The odds of live birth asso-
ciated with transfer of grade A embryos were
significantly higher than for grade B embryos (1.99,
1.26 to 3.13; P=0.003) (table 5). The chance of a live
birth was 66% greater after IVF than after intra-
cytoplasmic sperm injection (1.66, 1.15 to 2.38;
P=0.006). Compared with male infertility, female
infertility was associated with a reduction in the odds
of a live birth (0.58, 0.38 to 0.88; P=0.02).
Multiple live births
Fewermultiplebirthsoccurredafteroneelectivesingle
embryo transfer cycle (3/181, 2%) than after a double
embryotransfercycle(84/285,29%)withanoddsratio
of 0.04 (0.01 to 0.12; P<0.001). No other covariates
had a significant effect on multiple live births.
Cumulative live births
Onlytwotrialshadanadditionalfrozensingleembryo
transfer after the initial fresh elective single embryo
transfer (both Thurintrials). This resulted in a cumula-
tive live birth ratesimilar to that after onefreshdouble
embryo transfer (132/350 (38%) v 149/353 (42%);
0.85, 0.62 to 1.15), with a minimal cumulative risk of
multiple live birth (1/132 (1%) v 47/149 (32%); 0.02,
0.002 to 0.12).
Miscarriage
The rate of miscarriage in the elective single embryo
transfer group (60/245, 24%) was higher than in the
double embryo transfer group (63/355, 18%), with an
odds ratio of 1.52 (1.01 to 2.28). There was, however,
evidence of significant heterogeneity between the
trials. When we excluded the two trials that caused
the heterogeneity (Davies, 2003; Thurin, 2005) the
Table 4 |Characteristics of treatment received by randomised
group: elective single embryo transfer (eSET) or double
embryo transfer (DET). Figures are numbers (percentages)
unless stated otherwise
eSET
(n=683)
DET
(n=684)
Type of treatment:
IVF 365 (53) 388 (57)
Intracytoplasmic sperm injection 318 (47) 293 (43)
Both 0 2 (0.3)
Missing 0 1 (0.1)
Median (IQR) No of embryos available for
transfer in first fresh cycle
5( 3 - 8 ) 5( 3 - 7 )
Missing 0 2 (0.3)
Embryos transferred in first fresh cycle:
0 2 (0.3) 1 (0.1)
1 677 (99) 7 (1)
2 4 (1) 676 (99)
Missing 0 0
Day of fresh embryo transfer:
Day 2 540 (79) 539 (79)
Day 3 130 (19) 131 (19)
Day 5 10 (1.5) 9 (1.3)
No transfer 2 (0.3) 1 (0.1)
Missing 1 (0.1) 4 (0.6)
Median (IQR) No of blastomeres* 4 (4-5) 4 (4-6)
Missing 30 (4) 32 (5)
Grade of embryos transferred*†
Grade A 571 (84) 597 (87)
Grade B 79 (12) 51 (7)
Missing 31 (5) 35 (5)
IQR=interquartile range.
*For DET, embryo with largest number of cells chosen.
†Grade A=four cells transferred on day 2 or more than six cells
transferred on day 3; grade B=all others.
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P=0.06).
Subgroup analyses
Age group
Weexcludedfive(0.4%)womenfromanalysisbecause
of missing data on age. Younger women (<33) had a
higher odds of a live birth than older women (≥33)
(336/915 (37%) v 130/446 (29%); 1.37, 1.05 to 1.77;
P=0.02). As before, the odds of a live birth in women
randomised to elective single embryo transfer were
half those for women who received a double embryo
transfer(0.50,0.40to0.63;P<0.001).Theeffectofelec-
tive single embryo transfer versus double embryo
transfer on live birth did not differ between younger
(131/461 (28%) v 205/454 (45%)) and older (50/219
(23%) v 80/227 (35%); P=0.60) women. Figure 3
shows the odds ratios for both groups by age .
There was no difference between the odds of multi-
ple live birth for youngerversus older women(64/336
(19%) v 23/130 (18%); 1.06, 0.58 to 1.91; P=0.86). As
before, the odds of a multiple live birth in women ran-
domisedtoelectivesingleembryotransferweresignif-
icantly smaller than for women who received double
embryo transfer (0.04, 0.01 to 0.12; P<0.001). The
interaction between elective single versus double
Table 5 |Predictors of live birth after elective single embryo transfer (eSET) and double embryo transfer (DET). Figures are
numbers (percentages) unless stated otherwise
Baseline characteristics
Live birth* Odds ratio (95% CI)
Yes No Crude† Adjusted‡
Randomised treatment:
DET 285/466 (61) 398/900 (44) 1 1
eSET v DET 181/466 (39) 502/900 (56) 0.50 (0.40 to 0.63)§ 0.50 (0.39 to 0.63)§
Mean (SD) age of woman (years) 31.0 (3.4) 31.5 (3.5) 0.97 (0.94 to 1.01) —
Median (IQR) BMI of woman 23.5 (21.2-26.0) 23.2 (21.2-26.4) 0.99 (0.96 to 1.02) —
Median (IQR) duration of infertility (years) 3.0 (2.0-4.0) 3.1 (2.1-4.4) 0.96 (0.90 to 1.02) —
Type of infertility:
Primary 333/454 (73) 663/884 (75) 1 —
Secondary v primary 121/454 (27) 221/884 (25) 1.03 (0.79 to 1.35) —
Primary cause of infertility:
Male 187/465 (40) 368/897 (41) 1 1
Female v male 108/465 (23) 239/897 (27) 0.86 (0.64 to 1.16) 0.58 (0.38 to 0.88)¶
Unexplained v male 96/465 (21) 154/897 (17) 1.17 (0.85 to 1.61) 0.79 (0.51 to 1.22)
Other/mixed v male 74/465 (16) 136/897 (15) 0.99 (0.69 to 1.41) 0.77 (0.51 to 1.15)
Type of treatment:
ICSI 190/465 (41) 420/898 (47) 1 1
IVF v ICSI 275/465 (59) 478/898 (53) 1.25(0.99to1.59)** 1.66 (1.15 to 2.38)††
Day of embryo transfer:
Day 2 366/465 (79) 712/893 (80) 1 —
Day 3 v day 2 95/465 (20) 166/893 (19) 1.10 (0.70 to 1.74) —
Day 5 v day 2 4/465 (1) 15/893 (2) 0.51 (0.17 to 1.58) —
Median (IQR) No of embryos available for transfer 5.0 (4.0-8.0) 5.0 (3.0-7.0) 1.03 (1.00 to 1.07) —
Quality of embryos transferred
Grade B 27/450 (6) 103/848 (12) 1 1
Grade A v grade B 423/450 (94) 745/848 (88) 1.93(1.23to3.04)†† 1.99 (1.26 to 3.13)††
SD=standard deviation; IQR=interquartile range; BMI=body mass index; ISCI=intracytoplasmic sperm injection.
*Means (SD) provided for normally distributed data; medians (IQR) presented for skewed data. Denominator differs because of missing values for
some characteristics.
†Estimated from separate logistic models adjusted for eSET v DET and trial.
‡One logistic model resulting from stepwise procedure. Adjusted for eSET v DET, trial, embryo grade, type of treatment, primary cause of infertility.
§P≤0.001.
¶0.01<P≤0.05.
**0.05<P≤0.1.
††0.001<P≤0.01.
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Fig 3 | Odds ratios of live birth for elective single embryo
transfer versus double embryo transfer by different subgroups
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the model as no multiple births occurred in women
aged over 32 who received elective single embryo
transfer. The rate of multiple live births for elective
single versus double embryo transfer, however, were
similar for younger women (3/131 (2%) v 61/205
(30%)) and older women (0/50 v 23/80 (29%)).
For embryo grade and duration of infertility sub-
group analyses, the odds ratios for elective single ver-
sus double embryo transfer were similar to those
reported for age group.
Embryo grade
Asembryogradewasmissingfor68(5%)women,they
could not be included in the analysis. Women who
received grade A embryos had higher odds of a live
birth than women with grade B embryos (423/1168
(36%) v 27/130 (21%); 1.93, 1.23 to 3.04; P=0.004).
The effect of elective single versus double embryo
transfer on live birth did not differ between grade A
(164/571 (29%) v 259/597 (43%)) and grade B (10/79
(13%) v 17/51 (33%)) embryos (P=0.21) (fig 3).
There was no difference between the odds of multi-
ple live birth for grade A embryos versus grade B
embryos (4/27 (15%) v 81/423 (19%); 1.59, 0.49 to
5.17;P=0.44).Wecouldnotfittheinteractionbetween
elective single versus double embryo transfer and
embryo grade in the model because no multiples
occurred in women randomised to elective single
embryotransferwhohadgradeBembryostransferred.
Therateofmultiplelivebirthsforelectivesingleversus
double embryo transfer, however, were similar for
grade A (3/164 (2%) v 78/259 (30%)) and grade B (0/
10 v 4/17 (24%)) embryos.
Duration of infertility
Data on duration of infertility was missing for 32
women (2%), who we excluded from this subgroup
analysis.Coupleswiththreeormoreyearsofinfertility
hadsimilaroddsofalivebirthtocoupleswithlessthan
threeyearsinfertility(153/460(33%)v298/873(34%);
1.02,0.79 to1.32;P=0.87).Theeffectofelectivesingle
versus double embryo transfer on live birth did not
differ between shorter (60/234 (26%) v 93/226 (41%))
and longer (115/432 (27%) v 183/441 (42%), P=0.14)
duration of infertility (fig 3).
Couples with three or more years of infertility had
the same chance of multiple births as couples who
experienced less than three years’ infertility (28/153
(18%) v 56/298 (19%); 0.97 (0.55 to 1.72), P=0.91).
The effect of elective single versus double embryo
transfer on multiple live birth did not differ between
shorter term (1/60 (2%) v 27/93 (29%)) and longer
term(2/115(2%)v54/183(30%))durationofinfertility
(p=0.95). For couples with under three year’s inferti-
lity, the odds ratio for multiple live birth rates for
eSET versus DET was 0.04 (0.005 to 0.29). In couples
who were infertile for three years or more, the odds
ratio was similar (0.04, 0.01 to 0.17).
Perinatal outcomes
Table 6 shows perinatal outcomes after elective single
versus double embryo transfer. One woman had miss-
ingvaluesforall perinataloutcomesandwasexcluded
from this analysis.
Birth weight
The odds of delivering at least one low birthweight
(<2500 g) baby after elective single embryo transfer
werea quarterofthoseassociatedwithdoubleembryo
transfer (table 6). After adjustment for gestational age,
this odds ratio rose, only slightly, to a third. For single-
tons born after elective single or double embryo trans-
fer,themeanbirthweightswere3373g(SD591g)and
3275 g (SD 773 g), respectively, and there was no sig-
nificant difference between them (P=0.18).
Term singleton birth
The odds of a term singleton birth (that is, over
37 weeks) after elective single embryo transfer were
almost five times higher than those after double
embryo transfer (4.93, 2.98 to 8.18) (table 6).
Preterm birth
Elective single embryo transfer was associated with a
significantly reduced risk of preterm birth at ≤37 com-
pleted weeks, with an odds ratio of 0.33 (0.20 to 0.55).
Theoddsofpretermbirthsat≤34completedweeksfor
elective single versus double embryo transfer were
similar to that for preterm births at ≤37 completed
weeks (table 6). Increasing maternal age significantly
reduced the odds of a preterm birth at ≤34 completed
weeks (adjusted odds ratio 0.86, 0.77 to 0.97).
For very preterm births (≤32 weeks) covariates
affecting the odds of this outcome included double
embryo transfer, higher female BMI, and longer dura-
tion of infertility. For each unit increase in BMI, the
odds of a preterm birth at ≤32 weeks increased by
16% (1.16, 1.04 to 1.30; P=0.01), and for each yearly
Table 6 |Perinatal outcomes after fresh elective single embryo transfer (eSET) versus fresh
double embryo transfer (DET) in women with live birth. Figures are numbers (percentages)
unless stated otherwise
eSET
(n=181)
DET
(n=284)
Odds ratio (95% CI)
Crude* Adjusted
Deliveryofatleastonelowbirthweight
baby (<2500 g)
14 (8%) 69 (24%) 0.26 (0.14 to 0.48) 0.36 (0.15 to 0.87)†
Term singleton delivery 158 (87%) 169 (60%) 4.93 (2.98 to 8.18) As crude‡
Preterm delivery (weeks):
24-37 23 (13%) 85 (30%) 0.33 (0.20 to 0.55)§ As crude‡
24-34 6 (3%) 29 (10%) 0.29 (0.12 to 0.72) 0.30 (0.12 to 0.75)¶
24-32 1 (<1%) 16 (6%) 0.09 (0.01 to 0.70) 0.08 (0.01 to 0.65)**
*Estimated from logistic model adjusted for eSET v DET and trial.
†Adjusted for gestational age. Bhattacharya trial excluded as no low birthweight babies.
10
‡No significant covariates, so adjusted as for crude odds ratio.
§Bhattacharya trial excluded as no preterm births.
10
¶Adjusted for female age. Bhattacharya,
10 Gerris et al,
29 and Thurin (2005)
9 excluded as no preterm births ≤
34 weeks.
**Adjusted for female BMI and duration of infertility. Davies, Bhattacharya,
10 Gerris et al,
29 and Thurin (2005)
9
excluded as no preterm births ≤32 weeks.
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birth increased by 52% (1.52, 1.15 to 2.03; P=0.004).
DISCUSSION
Main findings
Termsingletonlive birthratesafterasinglefreshcycle
ofelectivesingleembryotransferarehigherthanthose
associated with double embryo transfer. Compared
with double embryo transfer, elective single embryo
transfer has a significantly lower risk of preterm birth
and delivery of a low birthweight baby. As previously
reported in systematic reviews based on aggregated
data, elective single embryo transfer in a fresh IVF
cycleyieldsa lowerlive birthratethandoubleembryo
transfer,
8butthisdifferenceisalmostcompletelyover-
come by an additional fresh or frozen single embryo
transfercycle.Themultiplelivebirthrateafterelective
single embryo transfer is much lower than that asso-
ciated with double embryo transfer and comparable
with that observed in spontaneous pregnancies.
Strengths and limitations of the review
We carried out an extensive literature search, with no
language restrictions, minimising the risk of missing
information. Access to data at the level of the patient
enabled us to uncover previously unreported data,
improve the assessment of study quality, perform rig-
orous quality checks, standardise outcome measures,
and perform intention to treat analysis. We complied
with existing guidelines for the reporting of systematic
reviews and meta-analyses and were able to provide
data on previously unreported perinatal outcomes.
1516
We obtained individual patient data from alleligible
trials of cleavage stage elective single versus double
embryo transfer in IVF; the overall quality of received
data was good and there were few missing values. The
quality of the included studies was variable, with some
ofthe earlierpapersfailing toreportkeydetailssuch as
mechanism of randomisation, intention to treat analy-
sis, and a priori power calculation. We subsequently
obtained information about these factors by directly
communicating with the authors who were part of the
collaborative group. These responses suggest that the
source of error lay in reporting rather than faulty
design. Information regarding the quality of the three
unpublished studies was obtained from trial protocols
and personal communication with the trialists. These
trials had limited sample size (n=93 in total) compared
with the published trials, and two of the three were
stopped because of poor recruitment. Their inclusion
is important, however, as they alleviate systematic
bias.
31 Detailed information on trial quality allowed us
to be strict in our inclusion criteria of potential trials.
Variationsinentrycriteriaandclinicalprotocols(for
ovarian stimulation and embryo culture) among the
trials mean that we cannot exclude an element of clin-
ical heterogeneity within this review. Nearly all trials
focused on women with “good prognoses” so our find-
ings are not generalisable beyond this group. As most
of the trials reported outcomes after a single fresh IVF
cycle,cumulativeoutcomesoffreshfollowedbyfrozen
singleembryotransferwerebasedononlytwoSwedish
studies.
926
Meta-analysis of individual patient data
While this type of meta-analysis is more demanding in
terms of resources, time, and cooperation than meta-
analysis of aggregated patient data,
32 there are many
benefits.Theseincludetheabilitytoperformconsistent
datachecksandcleaning,havingacompletedatabaseto
analysealltherelevantvariablesfromallrelevanttrials,
the ability to analyse effects at patient level, and colla-
borationwithallthetrialists.
18Analternativemethodto
the one stage meta-analysis of individual patient data
doneinthisstudy could havebeen the two stage proce-
dure, where each study is analysed separately and the
summary estimates combined in an aggregated meta-
analysis. We chose the one stage approach because all
individual patient data were available from all eight
trials, and this allowed for the adjustment of potential
confounding factors and the exploration of treatment
effects and subgroup interactions.
Interpretation
Thisstudyconfirmsearlierresultsfromaggregatedsys-
tematic reviews that in a fresh IVF treatment cycle,
elective single embryo transfer is associated with a
reduced chance of live birth compared with double
embryo transfer but that the additional transfer of
another frozen single embryo in a successive cycle
results in a comparable live birth rate and virtually
eliminates the risk of twins.
833In the relatively homo-
geneous population of women who were recruited to
these trials (that is, younger women with good quality
embryos) elective single embryo transfer in a fresh
cycle resulted in lower rates of live birth than double
embryo transfer, irrespective of the age of the woman,
duration of infertility, and embryo quality. The effect
of elective single versus double embryo transfer was
similarbetweenthesubgroups.However,thenumbers
of women who belonged to the older age group and
received grade B quality embryos were smaller than
their opposing subgroups, and this could explain the
lack of a significant difference.
Elective single embryo transfer significantly reduced
theriskofpretermbirthandlowbirthweight,primarily
becauseoffewertwins.Themostappropriatemethodof
reporting outcomes in IVF remains debatable, but
many consider term singleton live birth to be a useful
measure of describing positive consequences of IVF—
that is, offspring who are likely to be healthy at birth.
34
We found that the chances of delivering a healthy new-
born (term singleton birth) after elective single embryo
transfer were higher than those after double embryo
transfer. On the other hand, double embryo transfer
(because of the higher risks of twins), increased female
BMI, and prolonged duration of infertility were asso-
ciated with very preterm births (≤32 weeks).
Despitethereducedoddsofalivebirth,theabsolute
proportion of women who had a baby after a fresh
RESEARCH
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tive single embryo transfer was an acceptable 27%—
probably reflecting the entry criteria, which encour-
aged the inclusion of a population with a favourable
prognostic profile. Again, because of the homoge-
neous nature of the sample,we were unable to identify
subgroups of women who were more likely to benefit
from elective single embryo transfer and compare
them with older women or women with poor quality
embryos. The two trials that did recruit older women
included too few agedover 36 tomake such a compar-
ison possible.
928 Since the publication of these trials,
however, observational data from Scandinavia has
confirmedthatapolicyofelectivesingleembryotrans-
fer has not compromised live birth rates, even for
women aged over 36.
135
We focused on embryo transfers performed at the
cleavage stage (two to three days after fertilisation),
and the results should be interpreted in light of this.
Since the trials included in this meta-analysis were
undertaken, many clinics have increased their use of
blastocyst transfers (day five after fertilisation). There
is still debate on which strategy leads to the best peri-
natal and neonatal outcomes. A recent study has sug-
gested an increased risk of preterm birth and
congenital malformations with blastocyst transfer,
36
whileearlypregnancylosshasbeenshowntobehigher
after embryo transfer at the cleavage stage.
37
Implications for practice
Our review should be useful in informing decision
making regarding the number of embryos to transfer
in IVF. Live birth rates after elective single embryo
transfer are high in women with a profile similar to
that in the trials included in this systematic review,
and a further increase (by means of double embryo
transfer) is associated with high rates of preterm birth
and low birthweight babies caused by twin pregnan-
cies. Given the opportunity for replacing a single fro-
zen thawed embryo in a subsequent cycle, elective
single embryo transfer should thus be the default
position.
38Itmustbeemphasisedthatasnearlyallcou-
plesrecruitedtothetrialsincludedinthisanalysishada
good prognostic profile, the results of our meta-analy-
sis are valid only for this group. The entry criteria in
these trials ensured that most participants were young,
and we were unable to establish the impact of unfa-
vourable prognosticators such as increased female
age.Whenastrategyofelectivesingleembryotransfer
is applied in couples with poorer prognosis (for exam-
ple,inolderwomen),wecannotruleoutthepossibility
that the cumulative live birth rate could shift in favour
of double embryo transfer.
Implications for policy
Recruitmentdatafromsixoftheeighttrialsincludedin
this study showed that a high total proportion of
women (out of those eligible) refused to participate
(4270/5788, 74%). These figures were not available
for the trials of Davies et al and Thurin (2005). While
many centres would consider it unethical to ask
couples for their reasons for declining randomisation,
one can speculate that in many instances the main rea-
son could be a preference for double embryo
transfer.
39 Though many clinicians consider multiple
pregnancy, which is associated with increased mater-
nal and perinatal morbidity and mortality,
12to be the
mostdetrimentaleffectofassistedreproduction,many
infertilecouplesarenotawareoftheserisks
40andshow
a clear preference for twins.
41-43 Many couples who
know about the complications associated with twins
believethattheirpersonalriskofanyadverseoutcome
is low, while others cannot imagine the effect such
potential events would have on their lives.
4243
The safety considerations of assisted reproduction
are paramount in the minds of policy makers and clin-
icians. The HFEA’s concerns about the multiple birth
rate with IVF in the UK are echoed by the Society of
Obstetricians and Gynaecologists of Canada and the
Canadian Fertility and Andrology Society, who have
highlighted the need to avoid iatrogenic twins.
744The
latteralsorecommendedthatemphasisinghealthysin-
gleton live birth as the measure of success “may be
beneficial in promoting a reduction in the number of
embryos transferred.”
44
Our results show that, despite a small reduction of
live birth rates in a fresh IVF cycle, elective single
embryo transfer does lower the risk of preterm birth
comparedwith doubleembryo transfer.After an addi-
tional fresh or frozen cycle, there is no significant dif-
ference in live birth rate between elective single and
double embryo transfer and the risk of a multiple
birth in the elective single embryo transfer group is
still much lower than in the double embryo transfer
group. This strategy involves an acceptance of the
need to undergo multiple cycles, involving fresh fol-
lowed by frozen embryo transfers, to achieve similar
rates of live birth. The associated inconvenience and
stress associated with this should, of course, be taken
into account. As some of these additional cycles are
frozenembryoreplacementcycles,notrequiringovar-
ian stimulation and oocyte retrieval (that is, surgery to
harvest the eggs), however, many would consider that
thisisarelativelysmallpricetopaycomparedwiththe
long term consequences of preterm birth.
45 Further-
more, a study by Thurin Kjellberg et al showed that
one fresh cycle elective single embryo transfer fol-
lowed by one frozen single embryo transfer was more
cost effective than one fresh double embryo transfer
from both a healthcare and societal perspective.
3
Implications for research
Further trials of elective single versus double embryo
transfer should focus on women with different prog-
nosticprofiles,suchasolderwomen.Inaddition,exist-
ing national databases should be examined to identify
whichwomenandembryoscouldbenefitfromapolicy
of single embryo transfer. Although costly and time
consuming compared with aggregated data meta-ana-
lysis, meta-analysis of individual patient data allows
the most definitive synthesis of available data and
shouldbepromotedinresearchinreproductivehealth.
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